CB Therapeutics
PrivateLast Round
Series A
May 10, 2021
Total Funding Raised
$370,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CB Therapeutics operates in Healthcare & Life Sciences and is based in Carlsbad, California. Its latest recorded funding round was a Series A round in May 2021.
CB Therapeutics is a synthetic biology company that designs, develops, and manufactures high-value molecules through precision fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CB Therapeutics Comparables
Compare CB Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellibre | 87% | |
| Khona Scientific, Inc. | 83% | |
| Biomedican | 82% |
For institutional investors. Book with your work email.
CB Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 10, 2021 | ||||
| Debt | May 3, 2020 | ||||
| Accelerator | Aug 1, 2018 | ||||
| Accelerator | Jul 25, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CB Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| re.Mind Capital | Series A |
| EvoNexus | Accelerator |
| 305 Ventures | Accelerator |
| Y Combinator | Accelerator |
| Healthspan Capital | Accelerator |
| Rebel Fund | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 479% MoM, from 259 to 1.5K.
For institutional investors. Book with your work email.
CB Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CB Therapeutics's valuation, stock price, and market status.
Is CB Therapeutics a public or private company?
CB Therapeutics is a private company.
What is the current stock price of CB Therapeutics?
CB Therapeutics is a private company, so its shares have no public market price. Caplight tracks CB Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CB Therapeutics worth (valuation)?
Valuation information for CB Therapeutics is not publicly available.
Can I buy CB Therapeutics stock?
CB Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CB Therapeutics's last funding round?
CB Therapeutics's most recent funding round was Series A on May 10, 2021.
Who are the main investors in CB Therapeutics?
Key investors in CB Therapeutics include re.Mind Capital, Y Combinator.
Will CB Therapeutics IPO soon?
No public IPO plans have been announced for CB Therapeutics.
How can I track CB Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in CB Therapeutics's shares on secondary markets.